Débora De Souza Pazini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Débora De Souza Pazini has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Paiva Araújo
Universidade Federal de Juiz de Fora, Brasil
1 shared publication - Ana Luiza Cabrera Martimbianco
Universidade Metropolitana de Santos
1 shared publication - Ananda Carvalho Martins
Universidade Federal de Juiz de Fora, Brazil
1 shared publication - E Paula
Universidade Estadual Paulista Júlio de Mesquita Filho, Brazil
1 shared publication - Enzo Silva Araújo Corrêa
Universidade Federal de Juiz de Fora
1 shared publication - Eulilian Dias de Freitas
Universidade Federal de Juiz de Fora, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (11) , e20241022
Conclusions of clinical trials assessing monoclonal antibodies and sponsored by pharmaceutical industry: a meta-research study
The objective of this study was to describe and critically appraise the conclusions of randomized clinical trials assessing monoclonal antibodies sponsored by the pharmaceutical industry. This is a meta-research study on conclusions' characteristics of randomized clinical trials with monoclonal antibodies as interventions sponsored by the pharmaceutical industry. A total of 82 publications were considered. Notably, 79.3% (65/82) of the trials were fully funded by the pharmaceutical industry, and sponsors had data and publishing rights in 70.7% (58/82). Among the fully sponsored studies, 78.5% (51/65) presented conclusions with a drug-favorable direction of the effect, and 30.8% (20/65) made some recommendations for clinical practice, of which 95% (19/20) were favorable to the drug. In relation to the partially funded studies, drug-favorable direction of effect was present in 68.8% (11/16) of conclusions, and 18.8% (3/16) recommended the drug for the practice, in which 66.7% (2/3) favored the drug. Positive direction of effect was more present in trials in which the sponsor owned data and publication (81.0%; 47/58), compared to trials where the funder did not (63.3%; 14/22). Only 13.4% (11/82) of included studies recognize the uncertainty in the estimates in the conclusions, and 37.4% (31/82) had a statement regarding the need for future studies. Most of the included randomized clinical trials on monoclonal antibodies funded by the industry concluded a drug-favorable direction of effect. Recommendations for practice were common, while recognition of uncertainty and statements regarding the need for future studies were less frequently present in the conclusion.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (11) , e20241022
Open AccessConclusions of clinical trials assessing monoclonal antibodies and sponsored by pharmaceutical industry: a meta-research study
The objective of this study was to describe and critically appraise the conclusions of randomized clinical trials assessing monoclonal antibodies sponsored by the pharmaceutical industry. This is a meta-research study on conclusions' characteristics of randomized clinical trials with monoclonal antibodies as interventions sponsored by the pharmaceutical industry. A total of 82 publications were considered. Notably, 79.3% (65/82) of the trials were fully funded by the pharmaceutical industry, and sponsors had data and publishing rights in 70.7% (58/82). Among the fully sponsored studies, 78.5% (51/65) presented conclusions with a drug-favorable direction of the effect, and 30.8% (20/65) made some recommendations for clinical practice, of which 95% (19/20) were favorable to the drug. In relation to the partially funded studies, drug-favorable direction of effect was present in 68.8% (11/16) of conclusions, and 18.8% (3/16) recommended the drug for the practice, in which 66.7% (2/3) favored the drug. Positive direction of effect was more present in trials in which the sponsor owned data and publication (81.0%; 47/58), compared to trials where the funder did not (63.3%; 14/22). Only 13.4% (11/82) of included studies recognize the uncertainty in the estimates in the conclusions, and 37.4% (31/82) had a statement regarding the need for future studies. Most of the included randomized clinical trials on monoclonal antibodies funded by the industry concluded a drug-favorable direction of effect. Recommendations for practice were common, while recognition of uncertainty and statements regarding the need for future studies were less frequently present in the conclusion.
- Open Access
- 1 June 2023
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 28 (6) , 1607-1617
Tipificação e fatores associados à ocorrência de violência em pessoas em situação de rua em um município de Minas Gerais, Brasil
Resumo O estudo objetivou tipificar a violência sofrida pela população em situação de rua (PSR) e analisar os fatores associados em um município de médio porte de Minas Gerais. Foi efetuado um estudo epidemiológico transversal analítico, que utilizou um questionário estruturado para obter informações sobre dados sociodemográficos, saúde, comportamentos de risco e ocorrência de violência entre a PSR. Realizou-se regressão logística multivariada para verificar a associação entre exposições e desfecho. Dos 85 entrevistados, a maioria era do sexo masculino (75,3%), com idade entre 40 a 59 anos (59,5%), não brancos (86,3%), tabagistas (69,4%), etilistas (80,7%) e usuário de drogas ilícitas (53,6%). A prevalência geral de violência foi de 62,3%. Os tipos de violência mais relatados foram agressão verbal, física e ameaças. Ser mulher (OR 42,1; IC95% 27,8-638,0) e ser de cor não branca (OR 9,02; IC95% 1,33-61,1) estiveram associados ao maior risco de sofrer violência. Não ter morbidade (OR 0,14; IC95% 0,03-0,62) e viver nas ruas por até cinco anos (OR 0,18; IC95% 0,04-0,71) apresentaram associação negativa. Observa-se como a violência encontra-se presente no contexto urbano associada a sexo, raça, morbidade autorreferida e tempo de vida na rua.
- 1 June 2023
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 28 (6) , 1607-1617
Open AccessTipificação e fatores associados à ocorrência de violência em pessoas em situação de rua em um município de Minas Gerais, Brasil
Resumo O estudo objetivou tipificar a violência sofrida pela população em situação de rua (PSR) e analisar os fatores associados em um município de médio porte de Minas Gerais. Foi efetuado um estudo epidemiológico transversal analítico, que utilizou um questionário estruturado para obter informações sobre dados sociodemográficos, saúde, comportamentos de risco e ocorrência de violência entre a PSR. Realizou-se regressão logística multivariada para verificar a associação entre exposições e desfecho. Dos 85 entrevistados, a maioria era do sexo masculino (75,3%), com idade entre 40 a 59 anos (59,5%), não brancos (86,3%), tabagistas (69,4%), etilistas (80,7%) e usuário de drogas ilícitas (53,6%). A prevalência geral de violência foi de 62,3%. Os tipos de violência mais relatados foram agressão verbal, física e ameaças. Ser mulher (OR 42,1; IC95% 27,8-638,0) e ser de cor não branca (OR 9,02; IC95% 1,33-61,1) estiveram associados ao maior risco de sofrer violência. Não ter morbidade (OR 0,14; IC95% 0,03-0,62) e viver nas ruas por até cinco anos (OR 0,18; IC95% 0,04-0,71) apresentaram associação negativa. Observa-se como a violência encontra-se presente no contexto urbano associada a sexo, raça, morbidade autorreferida e tempo de vida na rua.
- Open Access
- 16 February 2022
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 10 (1) , 1-7
American Cutaneous Leishmaniasis in Eastern Minas Gerais: veiled reality of a neglected disease
Introduction: American cutaneous leishmaniasis (ACL) is considered an important public health problem in eastern Minas Gerais, Brazil, although neglected. Methods: A mixed study was carried out with a cross sectional and an ecological approach of time series type, using notified and confirmed ACL cases, 2007 to 2020. Primary and secondary data were used. Data were analyzed using descriptive and inferential statistics (simple linear regression, T test, Mann-Whitney, chi-square (χ2) at a 5% significance level). Results: A total of 219 cases were reported with a decreasing temporal trend, with a higher frequency being observed for the cutaneous form (82.6%), age group 40 to 59 years (32.1%), black race (56,4%) and completed elementary school (47.7%). Individuals with the mucous clinical form had a longer lesion time, a greater chance of not progressing to healing and used more ampoules of Meglumine Antimoniate when compared to patients with the cutaneous form. Conclusions: Different relationships were observed between the variables studied and the profile of involvement with what is described in the scientific literature, with the clinical form predominantly cutaneous and with a good prognosis.
- 16 February 2022
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 10 (1) , 1-7
Open AccessAmerican Cutaneous Leishmaniasis in Eastern Minas Gerais: veiled reality of a neglected disease
Introduction: American cutaneous leishmaniasis (ACL) is considered an important public health problem in eastern Minas Gerais, Brazil, although neglected. Methods: A mixed study was carried out with a cross sectional and an ecological approach of time series type, using notified and confirmed ACL cases, 2007 to 2020. Primary and secondary data were used. Data were analyzed using descriptive and inferential statistics (simple linear regression, T test, Mann-Whitney, chi-square (χ2) at a 5% significance level). Results: A total of 219 cases were reported with a decreasing temporal trend, with a higher frequency being observed for the cutaneous form (82.6%), age group 40 to 59 years (32.1%), black race (56,4%) and completed elementary school (47.7%). Individuals with the mucous clinical form had a longer lesion time, a greater chance of not progressing to healing and used more ampoules of Meglumine Antimoniate when compared to patients with the cutaneous form. Conclusions: Different relationships were observed between the variables studied and the profile of involvement with what is described in the scientific literature, with the clinical form predominantly cutaneous and with a good prognosis.